Literature DB >> 9375224

Semantic network abnormality predicts rate of cognitive decline in patients with probable Alzheimer's disease.

A S Chan1, D P Salmon, N Butters, S A Johnson.   

Abstract

The present study examined the relationship between rate of cognitive decline in patients with Alzheimer's disease (AD) and the integrity of the network of associations that comprise their semantic knowledge. The integrity of the semantic network of 12 AD patients was determined by comparing their networks to a standard normal control network derived with Pathfinder analysis, a multidimensional graphic analysis technique. A simple linear regression analysis, comparing the degree of semantic network deterioration with rate of cognitive decline as measured by the difference between the Dementia Rating Scale (DRS) scores obtained at the time of the testing of semantic knowledge (Year 1) and one year later (Year 2), was highly significant (r2 = .84; p < .001). These results suggest that a sensitive measure of the structural deterioration of semantic knowledge may be useful for predicting the rate of progression of cognitive changes in patients with AD.

Entities:  

Mesh:

Year:  1995        PMID: 9375224     DOI: 10.1017/s1355617700000291

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  14 in total

1.  Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation.

Authors:  A J Saykin; L A Flashman; S A Frutiger; S C Johnson; A C Mamourian; C H Moritz; J R O'Jile; H J Riordan; R B Santulli; C A Smith; J B Weaver
Journal:  J Int Neuropsychol Soc       Date:  1999-07       Impact factor: 2.892

Review 2.  Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.

Authors:  M Simard; R van Reekum
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 3.  Neuropsychological assessment of dementia.

Authors:  David P Salmon; Mark W Bondi
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

4.  Categorization of object descriptions in Alzheimer's disease and frontotemporal dementia: limitation in rule-based processing.

Authors:  Murray Grossman; Edward E Smith; Phyllis L Koenig; Guila Glosser; Jina Rhee; Kari Dennis
Journal:  Cogn Affect Behav Neurosci       Date:  2003-06       Impact factor: 3.282

5.  Hippocampal activation during episodic and semantic memory retrieval: comparing category production and category cued recall.

Authors:  Lee Ryan; Christine Cox; Scott M Hayes; Lynn Nadel
Journal:  Neuropsychologia       Date:  2008-03-18       Impact factor: 3.139

6.  Longitudinal verbal fluency in normal aging, preclinical, and prevalent Alzheimer's disease.

Authors:  Linda J Clark; Margaret Gatz; Ling Zheng; Yu-Ling Chen; Carol McCleary; Wendy J Mack
Journal:  Am J Alzheimers Dis Other Demen       Date:  2009-09-16       Impact factor: 2.035

7.  Neuropsychological profiles of an elderly cohort undergoing elective surgery and the relationship between cognitive performance and delirium.

Authors:  Tamara G Fong; Tammy T Hshieh; Bonnie Wong; Doug Tommet; Richard N Jones; Eva M Schmitt; Margaret R Puelle; Jane S Saczynski; Edward R Marcantonio; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2015-05-04       Impact factor: 5.562

8.  Estimating semantic networks of groups and individuals from fluency data.

Authors:  Jeffrey C Zemla; Joseph L Austerweil
Journal:  Comput Brain Behav       Date:  2018-06-06

9.  Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Rema Raman; Jenn Emond; Lawrence A Hansen; Eliezer Masliah; Leon J Thal
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

Review 10.  Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: a summary of the literature of the early 1990s.

Authors:  L D Rosenstein
Journal:  Neuropsychol Rev       Date:  1998-09       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.